Mercury Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2026 ,inter alia, to consider and approve Unaudited Financial Results ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mercury Laboratories Ltd has informed BSE that its Board of Directors will meet on Wednesday, February 11, 2026. The main agenda is to consider and approve the unaudited financial results for the quarter and nine months ended December 31, 2025 (Q3 FY26). The company has also closed its trading window from January 1, 2026, which will remain closed until 48 hours after the results are declared. This is a standard regulatory filing under SEBI's Listing Obligations and Disclosure Requirements Regulations, 2015.
No immediate impact on shareholders. Investors should watch for the actual Q3 FY26 results on or after February 11, 2026, as the numbers could move the stock once announced.